July 7, 2020 / 8:18 PM / a month ago

BRIEF-Sunesis Pharmaceuticals Plans To Review Strategic Alternatives

July 7 (Reuters) - Sunesis Pharmaceuticals Inc:

* SUNESIS PHARMACEUTICALS PROVIDES CORPORATE UPDATE

* SUNESIS PHARMACEUTICALS - REDUCTION IN WORKFORCE OF ABOUT 30% OF HEAD COUNT TO FOCUS ON DEVELOPMENT OF ITS FIRST-IN-CLASS PDK1 INHIBITOR SNS-510

* SUNESIS PHARMACEUTICALS INC SAYS REDUCTION IN WORKFORCE IS TO RIGHT SIZE COMPANY TO ACHIEVE ITS OBJECTIVES AND PRESERVE CASH RESOURCES

* SUNESIS PHARMACEUTICALS INC - REDUCTION IN WORKFORCE IS EXPECTED TO BE COMPLETED DURING CURRENT QUARTER

* SUNESIS PHARMACEUTICALS INC SAYS WILL PROVIDE COMPANY SUFFICIENT CASH TO FUND ITS OPERATIONS INTO Q2 OF 2021

* SUNESIS PHARMACEUTICALS INC - PLANS TO REVIEW STRATEGIC ALTERNATIVES Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below